Why Royalty Pharma Plc (RPRX) is One of the Most Undervalued Biotech Stocks to Buy Right Now [Yahoo! Finance]
Royalty Pharma plc - Class A Ordinary Shares (RPRX)
US:NASDAQ Investor Relations:
ir.reprosrx.com/investor-relations
Company Research
Source: Yahoo! Finance
April 17 that its board of directors approved the payment of a dividend for the second quarter of 2026 of $0.235 per Class A ordinary share. Management stated that the dividend will be paid on June 10, 2026, to shareholders of record at the close of business on May 15, 2026. In a separate development, Morgan Stanley lifted the price target on Royalty Pharma Plc (NASDAQ:RPRX) to $63 from $61 on April 10, reiterating an Overweight rating on the shares and adjusting models among the stocks under its biopharma coverage for IQVIA trends as well as intra-quarter updates ahead of the group's fiscal Q1 earnings reports. Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now? Royalty Pharma Plc (NASDAQ:RPRX) also announced on March 30 a research and development (R&D) co-funding agreement with Johnson & Johnson for a total of $500 million in 2026 and 2027, aimed at advancing the development of JNJ-4804, an investigational medicine for autoimmune diseases. Royalty
Show less
Read more
Impact Snapshot
Event Time:
RPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPRX alerts
High impacting Royalty Pharma plc - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RPRX
News
- Royalty Pharma Declares Second Quarter 2026 Dividend [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma Declares Second Quarter 2026 DividendGlobeNewswire
- Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026GlobeNewswire
- Royalty Pharma (RPRX) was given a new $63.00 price target by Morgan Stanley. They now have an "overweight" rating on the stock.MarketBeat
- Assessing Royalty Pharma (RPRX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
RPRX
Sec Filings
- 4/13/26 - Form 8-K
- 4/10/26 - Form ARS
- 4/10/26 - Form DEFA14A
- RPRX's page on the SEC website